Cold storage demand up amid coronavirus vaccine news

FOX Business’ Edward Lawrence provides details on the coronavirus vaccine from a cold storage factory.

LONDON– AstraZeneca says late-stage trials of its COVID-19 vaccine were "highly effective" in preventing disease.

Continue Reading Below

A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, the team reported Monday.

COVI-19 SHOTS COULD REACH US BY MID-DEC

Key researcher Dr. Andrew Pollard said scientists were pleased with the results. He said researchers found that if people were given a half dose followed by a full dose, rather than two full doses, protection rose to about 90%.

HERE'S HOW  MANY NEW YORKERS PLAN ON FLYING FOR THANKSGIVING

"These findings show that we have an effective vaccine that will save many lives," he said.

GET FOX BUSINESS ON THE GO BY CLICKING HERE 

Two other drugmakers, Pfizer and Moderna, last week reported preliminary results from late-stage trials showing that their COVID-19 vaccines were almost 95% effective.

Source: Read Full Article